BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17185949)

  • 1. [Obstructif sleep apnea-hypopnea syndrome: evolution of an old concept].
    Vecchierini MF
    Neurochirurgie; 2006 Nov; 52(5):432-42. PubMed ID: 17185949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of obstructive sleep apnea hypopnea syndrome on cardiovascular system].
    Dursunoğlu N; Dursunoğlu D
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):41-5. PubMed ID: 15755702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstructive sleep apnea/hypopnea syndrome.
    De Backer W
    Panminerva Med; 2013 Jun; 55(2):191-5. PubMed ID: 23676959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe obstructive sleep apnea-hypopnea syndrome with dilated cardiomyopathy leading to pulmonary hypertension: case report and literature review].
    Chen RK; Hong C; Zhou YM; Kuang AL; Zhang YT; Qing SM; Liu CL; Zhang NF
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jan; 40(1):46-51. PubMed ID: 28100362
    [No Abstract]   [Full Text] [Related]  

  • 5. Obstructive sleep apnea hypopnea syndrome and metabolic syndrome: a synergistic cardiovascular risk factor.
    Goodson BL; Wung SF; Archbold KH
    J Am Acad Nurse Pract; 2012 Dec; 24(12):695-703. PubMed ID: 23190127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sleep apnea syndromes and cardiovascular disease].
    Bounhoure JP; Galinier M; Didier A; Leophonte P
    Bull Acad Natl Med; 2005 Mar; 189(3):445-59; discussion 460-4. PubMed ID: 16149210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of nasal continuous positive airway pressure on heart rhythm in patients with obstructive sleep apnea/hypopnea syndrome.
    Pelechas E; Doina A
    Minerva Med; 2014 Jun; 105(3):255-60. PubMed ID: 24988091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sleep apneas, metabolic syndrome and cardiovascular risk: Data from the Pays de la Loire sleep cohort].
    Gagnadoux F; Priou P; Urban T; Meslier N; Trzepizur W
    Rev Pneumol Clin; 2017 Dec; 73(6):299-305. PubMed ID: 29122399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The research progress of OSAHS and cardiovascular disease].
    Zhang P; Guo WJ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Mar; 30(6):442-445. PubMed ID: 29871034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive recovery following positive airway pressure (PAP) in sleep apnea.
    Matthews EE; Aloia MS
    Prog Brain Res; 2011; 190():71-88. PubMed ID: 21531245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CPAP therapy induces favorable short-term changes in epicardial fat thickness and vascular and metabolic markers in apparently healthy subjects with obstructive sleep apnea-hypopnea syndrome (OSAHS).
    Kostopoulos K; Alhanatis E; Pampoukas K; Georgiopoulos G; Zourla A; Panoutsopoulos A; Kallianos A; Velentza L; Zarogoulidis P; Trakada G
    Sleep Breath; 2016 May; 20(2):483-93. PubMed ID: 26223484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure.
    Gasa M; Tamisier R; Launois SH; Sapene M; Martin F; Stach B; Grillet Y; Levy P; Pepin JL;
    J Sleep Res; 2013 Aug; 22(4):389-97. PubMed ID: 23409736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental shuttle walk test in the assessment of patients with obstructive sleep apnea-hypopnea syndrome.
    Billings CG; Aung T; Renshaw SA; Bianchi SM
    J Sleep Res; 2013 Aug; 22(4):471-7. PubMed ID: 23425321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiac consequences of the obstructive sleep apnea-hypopnea syndrome.
    Wieber SJ
    Mt Sinai J Med; 2005 Jan; 72(1):10-2. PubMed ID: 15682256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of nasal continuous positive airway pressure on endothelial function in obstructive sleep apnea-hypopnea syndrome with coronary heart disease].
    Zhang J; Tan H; Shi XN; Zheng XW; Li YM; Li SF; Ma ZY
    Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):188-91. PubMed ID: 16624147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ventilatory control in familial obstructive sleep apnea-hypopnea syndrome].
    Wang W; Kang J; Jin GM; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):763-6. PubMed ID: 15634390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictors of effective continuous positive airway pressure in patients with obstructive sleep apnea/hypopnea syndrome.
    Lai CC; Friedman M; Lin HC; Wang PC; Hwang MS; Hsu CM; Lin MC; Chin CH
    Laryngoscope; 2015 Aug; 125(8):1983-7. PubMed ID: 25582398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstructive sleep apnea syndrome: An important piece in the puzzle of cardiovascular risk factors.
    Costa C; Santos B; Severino D; Cabanelas N; Peres M; Monteiro I; Leal M
    Clin Investig Arterioscler; 2015; 27(5):256-63. PubMed ID: 25496654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The characteristics and determining factors of attention and short-term memory impairment in young patients with obstructive sleep apnea-hypopnea syndrome].
    Li Q; Li NZ; Li TT; Sun YQ; Wang J; Chen R
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):419-425. PubMed ID: 31189227
    [No Abstract]   [Full Text] [Related]  

  • 20. [Association between inflammation and cognitive function and effects of continuous positive airway pressure treatment in obstructive sleep apnea hypopnea syndrome].
    Sun L; Chen R; Wang J; Zhang Y; Li J; Peng W; Liu C
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(44):3483-7. PubMed ID: 25622738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.